Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.
In a study published in Science Immunology, researchers have shown that natural killer cells (NK cells), which are a fundamental part of the body’s immune system, can recognise many different viruses including global pathogens such as Zika, dengue and Hepatitis C viruses, through a single receptor called KIR2DS2.
Lead researcher Salim Khakoo, Professor of Hepatology, said the findings are very exciting and could change the way viruses are targeted by vaccines but warned that the research is still at an early stage, and animal studies/clinical trials will be needed to test the findings.
Vaccines work by stimulating the immune response to the coat of proteins on the virus enabling the body to fight off the virus and recognise it in the future. However, the viruses are able to change their coat proteins, helping the virus to evade the antibodies, meaning some viruses can be very hard to vaccinate against.
The Southampton team have shown that this NK cell receptor is able to target a non-variable part of the virus called the NS3 helicase protein, which is essential in making the virus work properly. Unlike other proteins, the NS3 helicase protein does not change, which allows the immune system to grab hold of it and let the NK cells deal with the threat.
Professor Khakoo said: “The NS3 helicase protein could be the key in unlocking the defence of lethal viruses that affect so many people around the world. It is very exciting to discover that other viruses similar to Hepatitis C, such as Zika virus, dengue virus, yellow fever virus, Japanese encephalitis virus and in fact all flaviviruses, contain a region within their NS3 helicase proteins that is recognised by exactly the same KIR2DS2 receptor. We believe that by targeting this NS3 helicase region, we could make a new type of vaccine based upon natural killer cells, which can be used to help protect people from these infections.”
The study, which was funded by the Wellcome Trust and the Medical Research Council, analysed DNA from more than 300 patients exposed to the Hepatitis C virus, which showed that the KIR2DS2 receptor was associated with successfully clearing the virus. The team then identified that the immune system targeted the NS3 helicase protein of this using the receptor and found that it prevented the virus multiplying.
They went on to demonstrate that this same mechanism icould be important for many different viruses for example the Zika and dengue viruses, which also contain a region within their NS3 helicase protein that is recognised by the KIR2DS2 receptor.
The researchers now need to determine whether these KIR2DS2+ NK cells are protective during acute flaviviral infections, and are hoping to develop a vaccine that targets natural killer cells. They believe that a similar process could be used to target cancer.
Professor Khakoo added: “Cancer treatments that use the body’s own immune system are becoming more common. Our findings present a completely new strategy for virus therapeutics which could be easily translated into the field of cancer. The next few years are going to be very exciting in this field.”
The Latest on: Vaccine for viruses
- Alberta flu vaccines will be offered up beginning Monday on October 22, 2017 at 4:36 pm
Starting Monday, Albertans can get their free flu shot and public health officials are encouraging everyone over the age of six months to get protected. Influenza immunization is offered free of charge to all Albertans who are eligible at Alberta Health ... […]
- The flu vaccine doesn’t cause the flu. Period. on October 22, 2017 at 4:01 pm
Flu vaccines are available, and so that means that the anti-vaccine brigade is out in force. The Daily Mail published an anti-vaccine op-ed by a former reality TV contestant named Katie Hopkins. It was followed by a shorter counter argument by a doctor ... […]
- A scientific breakthrough offers hope for an AIDS vaccine on October 22, 2017 at 2:54 pm
Scientists are inching toward developing a vaccine for AIDS, an immunodeficiency disease caused by the HIV virus that currently affects 36.7 million people worldwide, according to the World Health Organization. In a paper published in the journal Science ... […]
- Common Myths about the Flue Vaccine on October 22, 2017 at 2:33 pm
A flu vaccine is the first and best way to reduce your chances of getting the flu and spreading it to others. The CDC recommends that everyone 6 months of age and older receive a flu vaccine every year. Here are the most common myths about the flu vaccine. […]
- Stop The Excuses. Yes, You Should Get a Flu Vaccine Even if You’re Healthy. on October 22, 2017 at 11:56 am
Afraid of that yearly flu? Yeah, us too. The question remains the same every year; should you get the flu vaccination—especially if you are young and relatively healthy. Here’s how the flu vaccine works: doctors get together to try and predict what ... […]
- Reminder spurs flu vaccination of chronic disease patients on October 21, 2017 at 11:13 am
Children with chronic cardiac disease often don’t get a flu vaccine because their primary care physicians and cardiologists fail to specifically recommend it and because their parents are unaware influenza is risky for their children, reported Gilat ... […]
- Who Should Get the HPV Vaccine? on October 21, 2017 at 8:27 am
Of course, there is. The first vaccine to prevent disease caused by the human papilloma virus (HPV) was released over a decade ago. It wasn’t the first vaccine that prevents cancer (that was the vaccine against the hepatitis B virus, which can cause ... […]
- FDA approves better vaccine against painful shingles virus on October 20, 2017 at 8:13 pm
U.S. regulators have approved a new, more effective vaccine to prevent painful shingles, which is caused by the chickenpox virus. Drugmaker GlaxoSmithKline said the Food and Drug Administration approved it late Friday. It will be the second shingles ... […]
- FDA approves improved vaccine against painful shingles virus on October 20, 2017 at 5:02 pm
(AP) -- A new, more effective vaccine to prevent painful shingles has been approved by U.S. regulators. Drugmaker GlaxoSmithKline said the Food and Drug Administration approved it late Friday. It will be the second vaccine for shingles, which is caused by ... […]
- Colorado flu season off to a busy start, but docs say this year’s vaccine is a good match for strains going around on October 12, 2017 at 8:20 am
As the flu season gets underway in Colorado, a state health official is warning that it is especially important for people this year to get the flu vaccine — because the specific flu strain seen most so far is especially nasty. The first statewide flu ... […]
via Google News and Bing News